BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, July 6, 2026
Home » Authors » John Fox

John Fox

Articles

ARTICLES

Progress made toward beating chronic viral infections

Aug. 10, 2016
By John Fox
HONG KONG – Two research teams have independently identified a specialized cytotoxic killer T-cell population and shown that boosting the number and killing ability of those cells may lead to an effective treatment for currently incurable lifelong viral infections, notably HIV.
Read More

Progress made toward beating chronic viral infections

Aug. 10, 2016
By John Fox
HONG KONG – Two research teams have independently identified a specialized cytotoxic killer T-cell population and shown that boosting the number and killing ability of those cells may lead to an effective treatment for currently incurable lifelong viral infections, notably HIV.
Read More

New technique offers gene editing without even cutting DNA

Aug. 9, 2016
By John Fox

New technique offers gene editing without cutting DNA

Aug. 8, 2016
By John Fox
HONG KONG – A modified version of the revolutionary gene-editing system known as clustered regularly interspaced short palindromic repeats – cellular apoptosis susceptibility protein (CRISPR/Cas), allows researchers to perform DNA substitutions without actually cleaving the DNA, according to a new Japanese study led by researchers at the University of Kobe.
Read More

Proteins acting as RNA-binders may point to new heart disease cure

Aug. 3, 2016
By John Fox
HONG KONG – A new study led by scientists at the Australian National University (ANU) has provided valuable insights into how the function of the human genome depends on RNA-binding proteins, an important discovery that could ultimately lead to the development of new treatments for heart disease.
Read More

Proteins acting as RNA-binders may point to new heart disease cure

Aug. 1, 2016
By John Fox
HONG KONG – A new study led by scientists at the Australian National University (ANU) has provided valuable insights into how the function of the human genome depends on RNA-binding proteins, an important discovery that could ultimately lead to the development of new treatments for heart disease.
Read More

Anti-parasitic drug shows potential for treating breast cancer

July 26, 2016
By John Fox

HONG KONG – The common anti-parasitic agent, ivermectin, may be a viable new option to treat breast cancer, reported Chinese researchers, who have demonstrated that it inhibited the proliferation of breast cancer cells and elucidated its mechanism of action in a new study.


Read More

Anti-parasitic drug shows potential for treating breast cancer

July 26, 2016
By John Fox
HONG KONG – The common anti-parasitic agent, ivermectin, may be a viable new option to treat breast cancer, reported Chinese researchers, who have demonstrated that it inhibited the proliferation of breast cancer cells and elucidated its mechanism of action in a new study.
Read More

Potential new target for candidiasis identified

July 20, 2016
By John Fox
HONG KONG – A collaborative study by U.S. and Chinese researchers has identified an immune system component responsible for the homeostatic control of innate immune responses to nosocomial invasive candidiasis, which represents a potential target that may lead to the development of treatments for the fungal infection.
Read More

Potential new target for candidiasis identified

July 20, 2016
By John Fox
HONG KONG – A collaborative study by U.S. and Chinese researchers has identified an immune system component responsible for the homeostatic control of innate immune responses to nosocomial invasive candidiasis, which represents a potential target that may lead to the development of treatments for the fungal infection.
Read More
View All Articles by John Fox

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 2, 2026.
  • CINP 2026: Prenatal and adolescent stress shape brain vulnerability

    BioWorld Science
    Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
  • Ontrack Therapeutics divulges compounds for neurodegenerative diseases

    BioWorld Science
    Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
  • IPO puzzle pieces

    Neuracle eyes Shanghai IPO as global BCI funding surges

    BioWorld
    Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
  • Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists

    BioWorld Science
    Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing